Dillon Michael P. 4
4 · IDEAYA Biosciences, Inc. · Filed Jul 29, 2021
Insider Transaction Report
Form 4
Dillon Michael P.
SVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-07-27$25.15/sh−10,000$251,460→ 98,789 total - Exercise/Conversion
Common Stock
2021-07-27$4.31/sh+5,000$21,550→ 108,789 total - Exercise/Conversion
Stock Option (right to buy)
2021-07-27−5,000→ 39,500 totalExercise: $6.92Exp: 2030-02-20→ Common Stock (5,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-07-27−5,000→ 67,735 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-07-27$6.92/sh+5,000$34,600→ 103,789 total
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades in prices ranging from $24.95 to $25.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F4]25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.